Director: Mitch A. Phelps, PhD

The Pharmacoanalytic Shared Resource (PhASR) supports pre-clinical and clinical drug development at The Ohio State University by providing high quality and cost-effective bioanalytical method development, quantitative sample analysis, and pharmacokinetic/pharmacodynamic experimental design, data analysis and modeling. Expertise among the PhASR personnel includes quantitative pharmacology; bioanalytical methodology, design of pharmacokinetic/pharmacodynamic studies in animal disease models and in humans enrolled in clinical trials; data analysis and modeling of PK/PD data to inform drug development decisions. The PhASR personnel are available for consultation on clinical or pre-clinical PK/PD experimental design and analysis.

PhASR's Goals

Provide the OSUCCC – James and broader research and drug development community with:

  • High-quality, state-of-the-art, cost-competitive analytical expertise and instrumentation for quantitation of drugs and metabolites in biological specimens
  • Pharmacokinetic data (real-time when necessary) to enable pharmacologic data to be incorporated into clinical decision-making during dose escalation and interpretation of patient response and toxicity or in pre-clinical drug development efforts
  • Expertise in pharmacokinetic/pharmacodynamic study design and data interpretation during submission of clinical protocols, grant proposals, study reports and publications

.

Contact PhASR

College of Pharmacy, Division of Pharmaceutics
241 Parks Hall
500 W. 12th Ave.
Columbus, OH 43210



441 Biomedical Research Tower
460 W. 12th Ave.
Columbus, OH 43210


phasr@osumc.edu


Availability: Monday-Friday, 8 a.m.-5 p.m.

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Find a Scientific Publication